Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Clinical trial NCT03179956 · TERMINATED

Trial details

NCT number: NCT03179956
Sponsor: Fox Chase Cancer Center
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2018-04-02
Primary completion: 2018-11-12
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.